407 related articles for article (PubMed ID: 33643026)
21. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.
Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G
Mov Disord; 2019 Mar; 34(3):396-405. PubMed ID: 30576008
[TBL] [Abstract][Full Text] [Related]
22. Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India.
Pavan S; Gorthi SP; Prabhu AN; Das B; Mutreja A; Vasudevan K; Shetty V; Ramamurthy T; Ballal M
Ann Indian Acad Neurol; 2023; 26(6):908-916. PubMed ID: 38229613
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
[TBL] [Abstract][Full Text] [Related]
24. A nutritional approach to microbiota in Parkinson's disease.
Uyar GÖ; Yildiran H
Biosci Microbiota Food Health; 2019; 38(4):115-127. PubMed ID: 31763115
[TBL] [Abstract][Full Text] [Related]
25. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease.
Huang P; Zhang P; Du J; Gao C; Liu J; Tan Y; Chen S
NPJ Parkinsons Dis; 2023 Jul; 9(1):115. PubMed ID: 37460569
[TBL] [Abstract][Full Text] [Related]
26. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
27. Altered gut microbiota in Parkinson's disease patients with motor complications.
Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
[TBL] [Abstract][Full Text] [Related]
28. The interplay between gut microbiota and the brain-gut axis in Parkinson's disease treatment.
Jia X; Wang Q; Liu M; Ding JY
Front Neurol; 2024; 15():1415463. PubMed ID: 38867886
[TBL] [Abstract][Full Text] [Related]
29. An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation.
Chen W; Bi Z; Zhu Q; Gao H; Fan Y; Zhang C; Liu X; Ye M
Am J Transl Res; 2021; 13(12):13710-13722. PubMed ID: 35035709
[TBL] [Abstract][Full Text] [Related]
30. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
[TBL] [Abstract][Full Text] [Related]
31. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
[TBL] [Abstract][Full Text] [Related]
32. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
[TBL] [Abstract][Full Text] [Related]
33. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
34. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease.
Yang D; Zhao D; Ali Shah SZ; Wu W; Lai M; Zhang X; Li J; Guan Z; Zhao H; Li W; Gao H; Zhou X; Yang L
Front Neurol; 2019; 10():1155. PubMed ID: 31781020
[TBL] [Abstract][Full Text] [Related]
35. Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism.
Wang W; Jiang S; Xu C; Tang L; Liang Y; Zhao Y; Zhu G
Front Aging Neurosci; 2022; 14():976316. PubMed ID: 36408101
[TBL] [Abstract][Full Text] [Related]
36. [The role of the gut microbiota in Parkinson's disease].
Verugina NI; Levin OS; Lyashenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):86-91. PubMed ID: 34870920
[TBL] [Abstract][Full Text] [Related]
37. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
38. Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients.
Gorecka-Mazur A; Krygowska-Wajs A; Furgala A; Li J; Misselwitz B; Pietraszko W; Kwinta B; Yilmaz B
Neurogastroenterol Motil; 2024 Jun; ():e14846. PubMed ID: 38873926
[TBL] [Abstract][Full Text] [Related]
39. Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
Yan Z; Li R; Shi W; Yao L
Metab Brain Dis; 2022 Oct; 37(7):2511-2520. PubMed ID: 35895243
[TBL] [Abstract][Full Text] [Related]
40. Intestinal histomorphological and molecular alterations in patients with Parkinson's disease.
Bellini G; Benvenuti L; Ippolito C; Frosini D; Segnani C; Rettura F; Pancetti A; Bertani L; D'Antongiovanni V; Palermo G; Del Prete E; Antonioli L; Nardini V; Morganti R; Pellegrini C; Bernardini N; Ceravolo R; Fornai M; Bellini M
Eur J Neurol; 2023 Nov; 30(11):3440-3450. PubMed ID: 36263629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
